NEAT1 and central nervous system cancer: To investigate the functional importance of NEAT1 PAS utilization in the production of NEAT1 isoforms in glioma, we utilized CRISPR-Cas9 to delete the NEAT1 PAS (NEAT1 ΔPAS) in the U373 GBM cell line.